Pear Therapeutics, Inc. — Net Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d3d9a7ac-be9c-4cc0-b0d7-0c749a20c65f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-75.5M | 2022-01-01 – 2022-12-31 | evidence 0001835567-23-000018 |
| FY 2021 | $-65.1M | 2021-01-01 – 2021-12-31 | evidence 0001835567-22-000010 |
| FY 2020 | $-97.0M | 2020-01-01 – 2020-12-31 | evidence 0001835567-22-000010 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Pear Therapeutics, Inc. — all facts · Revenue · Operating Income